Dr. Gralow on Adjuvant Bisphosphonates for Breast Cancer

Dr. Gralow on Future Research Into Bisphosphonates in Breast CancerПодробнее

Dr. Gralow on a Comparison of Toxicities and Patient-Stated Preference in the SWOG S0307 TrialПодробнее

Adjuvant Bisphosphonates in Breast CancerПодробнее

Dr. Gralow on the Use of Bisphosphonates in Early-Stage Breast CancerПодробнее

Dr. Julie Gralow Explains the Side Effects Associated With Zoledronic Acid for Breast CancerПодробнее

Dr. Gralow Gives an Analysis of the APT TrialПодробнее

Dr. Gralow Discusses Toxicities Experienced in the SWOG S0307 TrialПодробнее

Dr. Julie Gralow on Treating Breast Cancer Bone MetastasesПодробнее

Dr. Brufsky on Adjuvant Bisphosphonates for Patients with Breast CancerПодробнее

Dr. Julie Gralow Discusses the Antibody Drug Conjugate T-DM1 for Breast CancerПодробнее

Dr. Julie R. Gralow Discusses Findings from the RxPONDER Study Released at SABCS 2020Подробнее

Julie R. Gralow, MD: SWOG SO226 Trial and Bisphosphonates UpdateПодробнее

Dr. Tripathy on Bisphosphonates in Breast CancerПодробнее

Targeted Breast Cancer Treatment, Dr. Julie GralowПодробнее

Dr. Julie Gralow on breast cancerПодробнее

Dr. Julie Gralow on the Importance of Genetic Testing for Breast CancerПодробнее

Are bisphosphonates an effective treatment for early stage breast cancer?Подробнее

Dr. Gralow on the Science of Biosimilars and Implementation in Breast CancerПодробнее

Bisphosphonate Use in Breast CancerПодробнее